文献速递细菌感染、耐药与抗菌药物医院感染防控

机器学习评估抗生素暴露与产超广谱β-内酰胺酶革兰阴性菌定植的关联:多中心前瞻性队列研究

Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study.
PubMed 文献 · Clin Microbiol Infect · 2019-05-23

抗生素暴露与新发ESBL-GNB定植独立相关(HR 2.38;95%CI 1.29-4.40),单药治疗促定植风险高于联合治疗,头孢菌素在单药中排名第一。

要点

  • 抗生素暴露是新发ESBL-GNB定植的独立危险因素(HR 2.38;95%CI 1.29-4.40)。
  • 单药治疗促ESBL-GNB定植风险高于联合治疗,头孢菌素在单药中排名第一。
  • 年龄60-69岁(HR 1.19;95%CI 1.05-1.34)和春季(HR 1.25;95%CI 1.14-1.38)亦独立相关。

核心结论

  • 抗生素对肠道ESBL-GNB选择的影响因单药或联合用药及既往抗生素暴露而异。

主要发现

  • 抗生素治疗与否的新发ESBL-GNB定植发生率分别为22/1000暴露日和9/1000暴露日。
  • 调整回归分析中,抗生素暴露(HR 2.38;95%CI 1.29-4.40)、年龄60-69岁(HR 1.19;95%CI 1.05-1.34)和春季(HR 1.25;95%CI 1.14-1.38)与新定植独立相关。
  • 单药治疗促ESBL-GNB定植排名高于联合治疗;单药中头孢菌素第一、四环素第二、大环内酯第四、复方磺胺甲噁唑第七。
  • 头孢菌素联合用药时排名降低;不含头孢菌素的联合中喹诺酮类加碳青霉烯类排名最高(第八)。
  • 序贯治疗中,头孢菌素治疗30天内使用喹诺酮类排名最高(第十)。

临床怎么用

  • 临床应关注抗生素暴露患者的ESBL-GNB定植风险,尤其是单药使用头孢菌素者。
  • 联合用药可能降低部分抗生素促ESBL-GNB定植的风险,但需结合既往抗生素暴露评估。

局限性

  • 研究结果需在未来的抗生素管理干预临床试验中进一步探索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of the study was to measure the impact of antibiotic exposure on the acquisition of colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria (ESBL-GNB) accounting for individual- and group-level confounding using machine-learning methods. METHODS: Patients hospitalized between September 2010 and June 2013 at six medical and six surgical wards in Italy, Serbia and Romania were screened for ESBL-GNB at hospital admission, discharge, antibiotic start, and after 3, 7, 15 and 30 days. Primary outcomes were the incidence rate and predictive factors of new ESBL-GNB colonization. Random forest algorithm was used to rank antibiotics according to the risk of selection of ESBL-GNB colonization in patients not colonized before starting antibiotics. RESULTS: We screened 10 034 patients collecting 28 322 rectal swab samples. New ESBL-GNB colonization incidence with and without antibiotic treatment was 22/1000 and 9/1000 exposure-days, respectively. In the adjusted regression analyses, antibiotic exposure (hazard ratio (HR) 2.38; 95% CI 1.29-4.40), age 60-69 years (HR 1.19; 95% CI 1.05-1.34), and spring season (HR 1.25; 95% CI 1.14-1.38) were independently associated with new colonization. Monotherapy ranked higher als combination therapy in promoting ESBL-GNB colonization. Among monotherapy, cephalosporins ranked first followed by tetracycline (second), macrolide (fourth) and cotrimoxazole (seventh). Overall the ranking of cephalosporins was lower when used in combination. Among combinations not including cephalosporins, quinolones plus carbapenems ranked highest (eighth). Among sequential therapies, quinolones ranked highest (tenth) when prescribed within 30 days of therapy with cephalosporins. CONCLUSIONS: Impact of antibiotics on selecting ESBL-GNB at intestinal level varies if used in monotherapy or combination and according to previous antibiotic exposure. These finding should be explored in future clinical trials on antibiotic stewardship interventions. CLINICAL TRIAL REGISTRATION: NCT01208519.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Tacconelli E, Górska A, De Angelis G, et al. Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study. Clin Microbiol Infect. 2019. PMID: 31128285. doi:10.1016/j.cmi.2019.05.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。